Your browser doesn't support javascript.
loading
FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors.
Mendrinou, E; Patsatsi, A; Zafiriou, E; Papadopoulou, D; Aggelou, L; Sarri, C; Mamuris, Z; Kyriakou, A; Sotiriadis, D; Roussaki-Schulze, A; Sarafidou, T; Vasilopoulos, Y.
Afiliação
  • Mendrinou E; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Patsatsi A; 2nd Dermatology Department, Medical School, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece.
  • Zafiriou E; Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece.
  • Papadopoulou D; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Aggelou L; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Sarri C; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Mamuris Z; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Kyriakou A; 2nd Dermatology Department, Medical School, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece.
  • Sotiriadis D; 2nd Dermatology Department, Medical School, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece.
  • Roussaki-Schulze A; Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece.
  • Sarafidou T; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
  • Vasilopoulos Y; Laboratory of Genetics, Comparative and Evolutionary Biology, Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Pharmacogenomics J ; 17(3): 237-241, 2017 06.
Article em En | MEDLINE | ID: mdl-27044681

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Resistência a Medicamentos / Fragmentos Fc das Imunoglobulinas / Fator de Necrose Tumoral alfa / Receptores de IgG / Polimorfismo de Nucleotídeo Único / Etanercepte / Variantes Farmacogenômicos / Anti-Inflamatórios Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Resistência a Medicamentos / Fragmentos Fc das Imunoglobulinas / Fator de Necrose Tumoral alfa / Receptores de IgG / Polimorfismo de Nucleotídeo Único / Etanercepte / Variantes Farmacogenômicos / Anti-Inflamatórios Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Grécia